This inventor holds 1 USPTO granted patent. Top assignee: Innospectra Corporation. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Shu-Ping Chien
Introduction
Shu-Ping Chien is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of drug identification technology. His innovative approach has led to the development of a unique system that enhances the accuracy and efficiency of drug scanning.
Latest Patents
Shu-Ping Chien holds a patent for a "Drug scanning and identification system and use method thereof." This system includes a spectrometer, a drug holder, a mobile device, and a drug identification model. The spectrometer is equipped with a light source, a diffraction grating, a light-absorption element, a wavelength selector, and a single-point photodetector. The drug holder features a transparent area where the drug is placed, surrounded by a light-absorption area. The mobile device is designed to send control commands to the spectrometer, enabling it to scan the drug and obtain spectrum data. This data is then transmitted to the drug identification model, which identifies the drug and displays the results on the mobile device. Shu-Ping Chien's patent is a testament to his innovative spirit and dedication to improving drug identification processes. He has 1 patent to his name.
Career Highlights
Shu-Ping Chien is currently associated with Innospectra Corporation, where he continues to work on advancing drug identification technologies. His expertise and innovative mindset have positioned him as a valuable asset in the field.
Collaborations
Shu-Ping Chien collaborates with talented individuals such as Hsi-Pin Li and Fei-Peng Chang. Their combined efforts contribute to the development of cutting-edge technologies in drug identification.
Conclusion
Shu-Ping Chien's contributions to drug scanning and identification technology highlight his innovative capabilities and commitment to enhancing healthcare solutions. His work continues to pave the way for advancements in the field.